Humanigen Inc (fka HGENQ)

[Fire Misleading]

Patients in trial are taking various background therapy and it’s a high probability another trial will be needed. In addition, the BET documentation states drugs will be tested with fewer patients initially. Then if the criteria is met, a larger clinical trial will take place.

Looks like this will take an considerable amount of time to study as Brazil nor the NIH trials have started dosing. Both should start this month. As a point of reference Mayo started several months ago and company only stating study has surpassed 50 percent.

In the meantime, vaccines are being dosed by the thousands

Dead money and opportunity costs are high. Stock went from $6’s to $1’s.